GOLRYVO Trademark

Trademark Overview

On Tuesday, March 10, 2020, a trademark application was filed for GOLRYVO with the United States Patent and Trademark Office. The USPTO has given the GOLRYVO trademark a serial number of 88829220. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Gilead Sciences Ireland UC. The GOLRYVO trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
golryvo

General Information

Serial Number88829220
Word MarkGOLRYVO
Filing DateTuesday, March 10, 2020
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7349825
Registration DateTuesday, April 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCARRIGTOHILL, CO. CORK
IE

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, March 1, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, February 21, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, February 21, 2024TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, August 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 22, 2023SOU EXTENSION 5 GRANTED
Wednesday, August 16, 2023SOU EXTENSION 5 FILED
Tuesday, August 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 3, 2023SOU EXTENSION 4 GRANTED
Friday, March 3, 2023SOU EXTENSION 4 FILED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 24, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 24, 2022SOU EXTENSION 3 FILED
Wednesday, August 24, 2022SOU TEAS EXTENSION RECEIVED
Thursday, March 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 28, 2022SOU EXTENSION 2 GRANTED
Monday, February 28, 2022SOU EXTENSION 2 FILED
Monday, February 28, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 19, 2021SOU EXTENSION 1 GRANTED
Thursday, August 19, 2021SOU EXTENSION 1 FILED
Thursday, August 19, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 8, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, September 22, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 22, 2020LETTER OF SUSPENSION E-MAILED
Tuesday, September 22, 2020SUSPENSION LETTER WRITTEN
Tuesday, September 22, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, September 22, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 22, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, September 22, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, September 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 2, 2020ASSIGNED TO LIE
Wednesday, August 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 30, 2020NON-FINAL ACTION E-MAILED
Saturday, May 30, 2020NON-FINAL ACTION WRITTEN
Friday, May 29, 2020ASSIGNED TO EXAMINER
Tuesday, March 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 13, 2020NEW APPLICATION ENTERED

Related Keywords

golryvo preparations pharmaceutical treatment disorders diseases anti respiratory autoimmune pulmonary kidney